Platelet activation in subjects with impaired glucose tolerance

References

• Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA 2002; 287: 2570–2581
   PubMed Web of Science ®Google Scholar
• Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: The current status on definition and intervention. Diabet Med 2002; 19: 708–723
   PubMed Web of Science ®Google Scholar
• Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95 783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233–240
   PubMed Web of Science ®Google Scholar
• World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complication. Part 1:. Diagnosis and Classification of Diabetes Mellitus. World Health Organization, Geneva 1999
   Google Scholar
• The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2000; 23, S4–19
   Google Scholar
• Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, et al. Expert committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160–3167
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay P, Chowdhury S. Drug therapy in prediabetes. J Indian Med Assoc 2005; 103: 603–608
   PubMedGoogle Scholar
• Pankow JS, Kwan DK, Duncan BB, Schmidt MI, Couper DJ, Golden S, Ballantyne CM. Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: The atherosclerosis risk in communities study. Diabetes Care 2007; 30: 325–331
   PubMed Web of Science ®Google Scholar
• Eguchi K, Tomizawa H, Ishikawa J, Hoshide S, Numao T, Fukuda T, Shimada K, Kazuomi, Kario K. Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes. Hypertens Res 2007; 30: 23–30
   PubMedGoogle Scholar
• Gao W, Qiao Q, Tuomilehto J. Post-challenge hyperglycaemia rather than fasting hyperglycaemia is an independent risk factor of cardiovascular disease events. Clin Lab 2004; 50: 609–615
   PubMedGoogle Scholar
• Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: The Funagata Diabetes Study. Diabetes Care 1999; 22: 920–924
   PubMed Web of Science ®Google Scholar
• Qiao Q, Pyorala K, Pyorala M, Nissinen A, Lindstrom J, Tilvis R, Tuomilehto J. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J 2002; 23: 1267–1275
   PubMed Web of Science ®Google Scholar
• Meigs JB, Nathan DM, D’Agostino Sr RB, Wilson PW. Fasting and postchallenge glycemia and cardiovascular disease risk: The Framingham Offspring Study. Diabetes Care 2002; 25: 1845–1850
   PubMed Web of Science ®Google Scholar
• DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: Comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 161: 397–405
   PubMedGoogle Scholar
• Calles-Escandon J, Garcia-Rubi E, Mirza S, Mortensen A. Type 2 diabetes: One disease, multiple cardiovascular risk factors. Coron Artery Dis 1999; 10: 23–30
   PubMed Web of Science ®Google Scholar
• Bath PM, Carney C, Markandu ND, MacGregor GA. Platelet volume is not increased in essential hypertension. J Hum Hypertens 1994; 8: 457–459
   PubMed Web of Science ®Google Scholar
• Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: Methodological issues. Platelets 2002; 13: 301–306
   PubMed Web of Science ®Google Scholar
• Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, Sunder-Plassmann R. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002; 117: 399–404
   PubMed Web of Science ®Google Scholar
• Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991; 338: 1409–1411
   PubMed Web of Science ®Google Scholar
• Tschoepe D, Esser J, Schwippert B, Rosen P, Kehrel B, Niewuenhuis HK, Gries FA. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost 1991; 17: 433–439
   PubMed Web of Science ®Google Scholar
• Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events?. Stroke 2004; 35: 1688–1691
   PubMed Web of Science ®Google Scholar
• Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996; 7: 157–161
   PubMed Web of Science ®Google Scholar
• Coban E, Ozdogan M, Yazicioglu G, Akcit F. The mean platelet volume in patients with obesity. Int J Clin Pract 2005; 59: 981–982
   PubMed Web of Science ®Google Scholar
• Kario K, Matsuo T, Nakao K. Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis. Clin Lab Haematol 1992; 14: 281–287
   PubMedGoogle Scholar
• Bath PM, Missouris CG, Buckenham T, MacGregor GA. Increased platelet volume and platelet mass in patients with atherosclerotic renal artery stenosis. Clin Sci (Lond) 1994; 87: 253–257
   PubMed Web of Science ®Google Scholar
• Sharpe PC, Trinick T. Mean platelet volume in diabetes mellitus. Q J Med 1993; 86: 739–742
   PubMedGoogle Scholar
• Tschope D, Langer E, Schauseil S, Rosen P, Kaufmann L, Gries FA. Increased platelet volume–sign of impaired thrombopoiesis in diabetes mellitus. Klin Wochenschr 1989; 67: 253–259
   PubMedGoogle Scholar
• Hekimsoy Z, Payzin B, Ornek T, Kandogan G. Mean platelet volume in Type 2 diabetic patients. J Diabetes Complications 2004; 18: 173–176
   PubMed Web of Science ®Google Scholar
• Papanas S, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, Lakasas G. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004; 15: 475–478
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levi RI, Fredricksen DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Bath PM. The routine measurement of platelet size using sodium citrate alone as the anticoagulant. Thromb Haemost 1993; 70: 687–690
   PubMed Web of Science ®Google Scholar
• Erhart S, Beer JH, Reinhart WH. Influence of aspirin on platelet count and volume in humans. Acta Haematol 1999; 101: 140–144
   PubMed Web of Science ®Google Scholar
• Coban E, Bostan F, Ozdogan M. The mean platelet volume in subjects with impaired fasting glucose. Platelets 2006; 17: 67–69
   PubMed Web of Science ®Google Scholar
• Dogru T, Tasci I, Sonmez A, Genc H, Gok M, Yilmaz MI, Ural AU, Olgun A, Kilic S, Bozoglu E, et al. The plasma levels of soluble P-selectin in subjects with prediabetes. Int J Clin Pract 2006; 60: 1048–1052
   PubMed Web of Science ®Google Scholar
• Koltai K, Feher G, Kesmarky G, Keszthelyi Z, Czopf L, Toth K. The effect of blood glucose levels on hemorheological parameters, platelet activation and aggregation in oral glucose tolerance tests. Clin Hemorheol Microcirc 2006; 35: 517–525
   PubMed Web of Science ®Google Scholar
• Gokulakrishnan K, Deepa R, Mohan V, Gross MD. Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome  – the Chennai Urban Rural Epidemiology Study. Metabolism 2006; 55: 237–242
   PubMed Web of Science ®Google Scholar
• Maiello M, Boeri D, Bonadonna R, Odetti P, Saccarello A, Adezati L. Platelet and clotting activities after cold stress in diabetic patients. Thromb Res 1988; 50: 885–894
   PubMed Web of Science ®Google Scholar
• Schafer A, Widder J, Eigenthaler M, Bischoff H, Ertl G, Bauersachs J. Increased platelet activation in young Zucker rats with impaired glucose tolerance is improved by acarbose. Thromb Haemost 2004; 92: 97–103
   PubMedGoogle Scholar
• Petersen JL, McGuire DK. Impaired glucose tolerance and impaired fasting glucose  – a review of diagnosis, clinical implications and management. Diab Vasc Dis Res 2005; 2: 9–15
   PubMedGoogle Scholar